KB

Krishna Bhavani Kona

Active Director Designated Partner DIN 08571804
DIN 08571804 First appointment Sep 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value •••• Premium profile

About Krishna Bhavani Kona

Data last updated:

Krishna Bhavani Kona is a Designated Partner at Invel Pharmaceuticals Llp (since 2019). The company operates in Pharma. Invel Pharmaceuticals Llp reported revenue of ₹21.6 Lakh (FY 2023).

DIN 08571804
Primary Designation Designated Partner
Industry Pharma
First Appointment 25 Sep 2019
Oldest Company Age 7 yrs
Largest company Invel Pharmaceuticals Llp · ₹21.6 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Sep 20192019₹21.6 Lakh (FY 2023)Active

Board colleagues of Krishna Bhavani Kona

NameDINCompanyDesignation
Seetha Ramulu Kompella09660277Invel Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Invel Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Krishna Bhavani Kona

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Bhavani Kona

Krishna Bhavani Kona currently holds 1 directorship: Invel Pharmaceuticals Llp (Designated Partner, since 25 Sep 2019, revenue ₹21.6 Lakh (FY 2023)).

Krishna Bhavani Kona was first appointed on 25 Sep 2019 as Designated Partner at Invel Pharmaceuticals Llp.

The current boards of Krishna Bhavani Kona's companies include Seetha Ramulu Kompella (Invel Pharmaceuticals Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available